The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a promising breakthrough. Unlike subcutaneous injections, this technique offers a less invasive way to deliver https://zubairtdys783569.win-blog.com/22220581/glp-1-patches-a-new-approach-to-diabetes-control